Key facts
- Notable investors include Guangzhou Jinkong Fund, Guangdong Yuecai Venture Capital, Guangzhou Guangyao Capital, Gaotong Pacs, Guangzhou Hi-tech Investment Group — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for SiDe Intelligent Digestive Examination
- ·The full record, as it builds
Funding rounds
No funding rounds for SiDe Intelligent Digestive Examination are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SiDe Intelligent Digestive Examination
Developer of AI-enabled medical technologies intended for healthcare institutions, diagnostic centers, and clinical teams. The company develops AI-enabled technology and medical devices and provides diagnostic services for gastroenterology using machine learning frameworks, enabling patients to realize large-scale, affordable gastric disease self-examination and health screening options to detect major gastrointestinal diseases.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2019
- Employees
- 11
- Website
- sidece.com/
- Ownership
- Privately Held (backing)
SiDe Intelligent Digestive Examination doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SiDe Intelligent Digestive Examination shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SiDe Intelligent Digestive Examination in its N-PORT filings yet. We sweep new filings monthly.